Nicholas Bodenberger Center for Peptide Pharmaceuticals, Faculty of Natural Science Ulm University Biography Publications Institution JoVE Articles Nicholas Bodenberger has not added a biography. If you are Nicholas Bodenberger and would like to personalize this page please email our Author Liaison for assistance. Publications Lectin-mediated Reversible Immobilization of Human Cells into a Glycosylated Macroporous Protein Hydrogel As a Cell Culture Matrix Scientific Reports. Jul, 2017 | Pubmed ID: 28733655 Beyond Bread and Beer: Whole Cell Protein Extracts from Baker's Yeast As a Bulk Source for 3D Cell Culture Matrices Applied Microbiology and Biotechnology. Mar, 2017 | Pubmed ID: 27864602 Evaluation of Methods for Pore Generation and Their Influence on Physio-chemical Properties of a Protein Based Hydrogel Biotechnology Reports (Amsterdam, Netherlands). Dec, 2016 | Pubmed ID: 28352549 Enkelt att använda arkitekturer i Protein-baserade hydrogeler för Cell kultur applikationer Nicholas Bodenberger1, Dennis Kubiczek1, Frank Rosenau1 1Center for Peptide Pharmaceuticals, Faculty of Natural Science, Ulm University JoVE 55813 Biochemistry Kvantifiering av Immunsuppressivum takrolimus på torkade blodfläckar Använda LC-MS / MS Touraj Shokati1, Nicholas Bodenberger1, Holly Gadpaille1, Björn Schniedewind1, Alexander A. Vinks2, Wenlei Jiang3, Rita R. Alloway4, Uwe Christians1 1iC42 Clinical Research and Development, University of Colorado, Anschutz Medical Campus, 2Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, 3Food and Drug Administration (FDA), Center of Drug Evaluation Research - Office of Generic Drugs, 4Transplant Clinical Research, University of Cincinnati Medicine
Enkelt att använda arkitekturer i Protein-baserade hydrogeler för Cell kultur applikationer Nicholas Bodenberger1, Dennis Kubiczek1, Frank Rosenau1 1Center for Peptide Pharmaceuticals, Faculty of Natural Science, Ulm University JoVE 55813 Biochemistry
Kvantifiering av Immunsuppressivum takrolimus på torkade blodfläckar Använda LC-MS / MS Touraj Shokati1, Nicholas Bodenberger1, Holly Gadpaille1, Björn Schniedewind1, Alexander A. Vinks2, Wenlei Jiang3, Rita R. Alloway4, Uwe Christians1 1iC42 Clinical Research and Development, University of Colorado, Anschutz Medical Campus, 2Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, 3Food and Drug Administration (FDA), Center of Drug Evaluation Research - Office of Generic Drugs, 4Transplant Clinical Research, University of Cincinnati Medicine
